Skip to main content

Peer Review reports

From: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

Original Submission
18 Jan 2024 Submitted Original manuscript
2 Apr 2024 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
3 Apr 2024 Editorially accepted
1 May 2024 Article published 10.1186/s13063-024-08091-z

You can find further information about peer review here.

Back to article page